[HTML][HTML] Downregulation of the let‑7 family of microRNAs may promote insulin receptor/insulin‑like growth factor signalling pathways in pancreatic ductal …
EE Nweke, M Brand - Oncology Letters, 2020 - spandidos-publications.com
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer type characterized by
dysregulated cell signalling pathways and resistance to treatment. The insulin‑like growth …
dysregulated cell signalling pathways and resistance to treatment. The insulin‑like growth …
[HTML][HTML] Polyethyleneglycol-Betulinic Acid (PEG-BA) polymer-drug conjugate induces apoptosis and antioxidation in a biological model of pancreatic cancer
Pancreatic cancer (PC) is one of the most aggressive solid malignancies with poor treatment
response and low survival rates. Herbal medicines such as betulinic acid (BA) have shown …
response and low survival rates. Herbal medicines such as betulinic acid (BA) have shown …
[HTML][HTML] SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related …
Pancreatic cancer accounts for 2.8% of new cancer cases worldwide and is projected to
become the second leading cause of cancer-related deaths by 2030. Patients of African …
become the second leading cause of cancer-related deaths by 2030. Patients of African …
[HTML][HTML] Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry
…, M Smith, G Candy, J Devar, EE Nweke - Clinical Proteomics, 2023 - Springer
Background Gallbladder cancer (GBC) is a lethal cancer with a poor prognosis. The lack of
specific and sensitive biomarkers results in delayed diagnosis with most patients presenting …
specific and sensitive biomarkers results in delayed diagnosis with most patients presenting …
[HTML][HTML] Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches
KR Xulu, EE Nweke, TN Augustine - Frontiers in Genetics, 2023 - frontiersin.org
The burden of breast cancer continues to increase worldwide as it remains the most diagnosed
tumor in females and the second leading cause of cancer-related deaths. Breast cancer …
tumor in females and the second leading cause of cancer-related deaths. Breast cancer …
[HTML][HTML] Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer
…, G Patrick Candy, EE Nweke - Molecular …, 2020 - spandidos-publications.com
Pancreatic cancer is an aggressive cancer, making it a leading cause of cancer‑related
deaths. It is characteristically resistant to treatment, which results in low survival rates. In …
deaths. It is characteristically resistant to treatment, which results in low survival rates. In …
Drug sensitivity and drug repurposing platform for cancer precision medicine
EE Nweke, DB Thimiri Govinda Raj - … Medicine, Volume 12: Stem Cells in …, 2021 - Springer
One of the critical Global challenges in achieving the UN Sustainable Development Goals 3
Good Health and Well Being is optimizing drug discovery and translational research for …
Good Health and Well Being is optimizing drug discovery and translational research for …
[HTML][HTML] Serum metabolomic and lipoprotein profiling of pancreatic ductal adenocarcinoma patients of african ancestry
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a characteristic dysregulated
metabolism. Abnormal clinicopathological features linked to defective metabolic and …
metabolism. Abnormal clinicopathological features linked to defective metabolic and …
[HTML][HTML] Targeting growth factor signaling pathways in pancreatic cancer: towards inhibiting chemoresistance
…, J Omoshoro-Jones, M Smith, EE Nweke - Frontiers in …, 2021 - frontiersin.org
Pancreatic cancer is one of the most deadly cancers, ranking amongst the top leading
cause of cancer related deaths in developed countries. Features such as dense stroma …
cause of cancer related deaths in developed countries. Features such as dense stroma …
[HTML][HTML] Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
Pancreatic Ductal Adenocarcinoma (PDAC) is a very lethal disease that typically presents at
an advanced stage and is non-compliant with most treatments. Recent technologies have …
an advanced stage and is non-compliant with most treatments. Recent technologies have …